Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Supporters often emphasize the opportunity for meaningful therapeutic benefits, particularly in diseases where conventional medications have proven ineffective. However, this is to evaluate the significant financial burden associated with CPI stem